Safety and efficacy of immunotherapy according to the age threshold of 80 years.
Bull Cancer
; 110(5): 570-580, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-36894391
Key words
80 and over; Aged; Cancer métastatique; Différences sexuelles; Efficacité; Efficacy; Immune checkpoint inhibitors; Immune-related adverse events; Inhibiteurs de points de contrôle immunitaires; Metastatic cancer; Sex-specific differences; Âgé de 80 ans et plus; Événements indésirables liés au système immunitaire
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
/
Lung Neoplasms
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Bull Cancer
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: